About Your Prescription
All prescriptions for compounded tirzepatide are issued by a licensed healthcare provider following a clinical evaluation. Prescriptions are filled by a state-licensed compounding pharmacy.
IMPORTANT: Sprout Health offers compounded tirzepatide, which is prepared by state-licensed pharmacies.
Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed.
FDA-approved tirzepatide products (such as Mounjaro® and Zepbound®) are available through traditional healthcare providers. Compounded tirzepatide should only be used when an FDA-approved medication cannot meet your specific medical needs.
Your provider will determine if compounded tirzepatide is appropriate for your individual situation.
Refill Process
Refill eligibility is determined through clinical review.
- Monthly Plans – Subscriptions rebill monthly. A follow-up questionnaire may be required before continued treatment is approved.
- Quarterly Plans – Subscriptions rebill every three months. Additional clinical review may be required before subsequent shipments are authorized.
- Your provider may adjust your dose during refill reviews based on your progress, side effects, and clinical needs.
- Medication type, dosage, and refill timing depend on clinical evaluation.
Dose Changes
- Do not change your dose without your provider’s approval
- If your dose is changed, verify the new concentration and injection volume with the pharmacy before your next injection
- Different refill shipments may contain different concentrations – always check the label on each new vial
Questions About Your Prescription?
Contact your clinician through the medical portal for any questions about your prescription, dosing, or treatment plan.